Find out how atogepant, a new migraine medication, offers rapid relief and promotes prevention of migraine attacks. Learn about its benefits and mechanism of action.

Novo Nordisk said on Friday it will begin a new trial of its experimental next-generation CagriSema drug in the first half of ...

Altimmune is redefining success in both obesity and MASH to position Pemvidutide in blue ocean categories. Read why I rate ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...

Shares in Novo Nordisk have fallen by more than a quarter after the Ozempic maker revealed a set of underwhelming results in ...

The company plans to leverage research and development incentives from the Australian Government to offset the trial costs.

A/S (Nasdaq: ASND) today announced that YORVIPATH® (palopegteriparatide; developed as TransCon PTH) is now commercially ...

(Figure S2); XPS quantitative analysis of commercial GO materials (Table S1); flowchart illustrating the experimental procedure of the acid–solvent method (Figure S3); FTIR spectra before and after ...

Novo Nordisk plans a new trial for its experimental drug, CagriSema, in 2025 after recent trials failed to meet weight-loss expectations. Despite aiding patients to reduce weight by 22.7%, it fell ...

During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December 7 to 10, preliminary results from the first human trial of QLS32015, a novel anticancer drug ...

I was about 23 and was still finding my feet socially in London. I’d always really been a champagne girl at heart but ...

Novo Nordisk shares on the NYSE rose over 5% in premarket trading Monday, reversing some losses from Friday’s plunge that ...